Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
149.00    7.00 (4.93%)
Bid:
142.50
Ask:
148.50
Spread: 6.00 (4.211%)
Market Cap: £285.60m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

SHARE REPURCHASE PROGRAMME

4 Jan 2019 07:00

RNS Number : 1739M
Franchise Brands PLC
04 January 2019
 

4 January 2019

 

FRANCHISE BRANDS PLC

("Franchise Brands", "the Group" or "the Company")

 

SHARE REPURCHASE PROGRAMME

 

Franchise Brands announces that from today until 30 June 2019 it will commence a programme to purchase ordinary shares of 0.5 pence each ("Ordinary Shares") in the Company, up to a value of £200,000 (the "Programme"). This is a continuation of the programme that commenced in 2018 and saw the Company purchase 200,000 Ordinary Shares into Treasury.

As announced on 12 December 2018, the Group, which is cash generative, intends to continue the share repurchase programme to offset the dilutive impact of employee share option awards, focusing on overall shareholder return. Ordinary Shares purchased under the Programme will therefore be held in Treasury to enable the Company to meet obligations arising from share option programmes. The total number of Ordinary Shares currently outstanding under option arrangements is 4,533,530 representing 5.8 per cent. of the Company's issued share capital.

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted by the Company's shareholders at the Company's Annual General Meeting on 25 April 2018 to purchase up to 7,773,203 shares. This authority will expire at the end of the next Annual General Meeting of the Company in 2019 or, if earlier, at the close of business on 25 July 2019 ("2018 Authority").

The Company has entered into an agreement with its joint broker, Dowgate Capital Stockbrokers Limited, to carry out on-market purchases of Ordinary Shares on its behalf under the Programme, including during any closed period of the Company which may fall during the period of the Programme. The Programme will also be conducted in accordance with the provisions of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes as necessary.

 

Enquiries:

 

Franchise Brands plc

+44 (0) 1562 826705

Stephen Hemsley, Executive Chairman

Chris Dent, Chief Financial Officer

Julia Choudhury, Corporate Development Director

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

 

+44 (0) 203 328 5656

Jeremy Porter/ Liz Kirchner

 

 

Dowgate Capital Stockbrokers (Joint Broker)

 

+44 (0) 203 903 7715

James Serjeant / Colin Climie

 

 

MHP Communications (Financial PR)

+44 (0) 203 128 8100

Katie Hunt

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSGMGGMRFFGLZM
Date   Source Headline
14th Apr 202312:10 pmRNSDirector/PDMR Shareholding
4th Apr 202312:08 pmRNSResult of Placing and Notice of GM
3rd Apr 20235:52 pmRNSProposed Acquisition and Launch of ABB
20th Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
13th Mar 202312:24 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSRule 19.6(c) confirmation
9th Mar 20234:54 pmRNSDividend Declaration and AGM date
9th Mar 20237:00 amRNSFinal Results
8th Mar 20235:20 pmRNSHolding(s) in Company
23rd Feb 20237:00 amRNSAnnual Results Presentation
22nd Feb 20237:00 amRNSAppointment of Joint Corporate Broker
25th Jan 20237:00 amRNSNotice of Results
23rd Jan 20237:00 amRNSNotice of Electronic Communications
13th Jan 20237:00 amRNSCapital Markets Day
12th Jan 20237:00 amRNSTrading Update
23rd Dec 20227:00 amRNSShare Purchase Programme
30th Nov 20225:00 pmRNSTotal Voting Rights
30th Nov 20224:40 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSExercise of share options, PDMR notification & TVR
1st Nov 20221:41 pmEQSFranchise Brands benefiting from strong contributions by Filta North America and Metro Rod
27th Oct 20227:00 amRNSQ3 Trading Update
3rd Oct 20227:00 amRNSAppointment of Interim CFO and grant of options
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
26th Jul 20227:00 amRNSInterim Results
5th Jul 20227:00 amRNSNotice of Interim Results
30th Jun 20225:00 pmRNSTotal Voting Rights
24th Jun 20224:45 pmRNSShare Purchase Programme
9th Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20222:11 pmRNSCompletion of Compulsory Acquisition & TVR
31st May 20225:00 pmRNSTotal Voting Rights
25th May 20227:00 amRNSIntegration of UK DLOs & earn-out of Willow Pumps
12th May 20227:00 amRNSInvestor Presentations
9th May 20222:51 pmRNSOffer closed and compulsory acquisition
5th May 20222:17 pmRNSOffer update - Acceptance, issue of equity and TVR
4th May 202210:52 amRNSForm 8.3 - Franchise Brands PLC
3rd May 20222:52 pmRNSForm 8.3 - Franchise Brands PLC
29th Apr 20225:00 pmRNSTotal Voting Rights
26th Apr 20222:20 pmRNSResult of AGM
26th Apr 20222:18 pmRNSForm 8.3 - Franchise Brands Plc
26th Apr 20227:00 amRNSAGM Statement and Trading Update
22nd Apr 202211:59 amRNSOffer acceptances, equity issue, acquisition & TVR
20th Apr 202211:08 amRNSForm 8.3 - Franchise Brands Plc
19th Apr 20227:00 amRNSOffer update – Notice of Offer closing
11th Apr 20223:43 pmRNSOffer acceptances, equity issue, acquisition & TVR
5th Apr 202212:56 pmRNSOffer acceptances, equity issue, acquisition & TVR
31st Mar 20225:00 pmRNSTotal Voting Rights
30th Mar 20227:00 amRNSPosting of Annual Report and Notice of AGM
28th Mar 20224:00 pmRNSForm 8.3 - Franchise Brands Plc
28th Mar 20223:56 pmRNSOffer acceptances, equity issue, acquisition & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.